Literature DB >> 16250418

Prolonged exposure to angiotensin-converting enzyme inhibitors during pregnancy. Fetal toxicity could be reversible.

A Shrim, H Berger, J Kingdom, A Hamoudi, P S Shah, G Koren.   

Abstract

QUESTION: I read in a Motherisk Update that angiotensin-converting enzyme (ACE) inhibitors are contraindicated during pregnancy. Many women, however, do not know they are pregnant for quite some time after conception. One of my patients was taking ACE inhibitors for 3 to 4 months while she was pregnant. How should I advise her? ANSWER: The deleterious effects ACE inhibitors have on fetuses were seen only after exposure during the second and third trimesters and were mostly secondary to renal damage. These effects can be reversed, as described in this Motherisk Update.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16250418      PMCID: PMC1479798     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  12 in total

Review 1.  Angiotensin converting enzyme inhibitors in pregnancy.

Authors:  J M Mastrobattista
Journal:  Semin Perinatol       Date:  1997-04       Impact factor: 3.300

2.  Unintended pregnancy in the United States.

Authors:  S K Henshaw
Journal:  Fam Plann Perspect       Date:  1998 Jan-Feb

3.  Angiotensin-converting-enzyme inhibitors in early pregnancy.

Authors:  G Y Lip; D Churchill; M Beevers; A Auckett; D G Beevers
Journal:  Lancet       Date:  1997-11-15       Impact factor: 79.321

4.  Possible risk with captopril in pregnancy: some animal data.

Authors:  F Broughton Pipkin; S R Turner; E M Symonds
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

5.  Angiotensin-converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalapril.

Authors:  C Kreft-Jais; P F Plouin; C Tchobroutsky; M J Boutroy
Journal:  Br J Obstet Gynaecol       Date:  1988-04

6.  Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-03-21       Impact factor: 17.586

7.  Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment.

Authors:  Sonia Tabacova; Ruth Little; Yi Tsong; Amarilys Vega; Carole A Kimmel
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003-12       Impact factor: 2.890

8.  Effects of captopril on blood pressure, placental blood flow and uterine oxygen consumption in pregnant rabbits.

Authors:  N D Binder; J J Faber
Journal:  J Pharmacol Exp Ther       Date:  1992-01       Impact factor: 4.030

9.  Effect of captopril on uterine blood flow and prostaglandin E synthesis in the pregnant rabbit.

Authors:  T F Ferris; E K Weir
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

10.  Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors.

Authors:  J M Piper; W A Ray; F W Rosa
Journal:  Obstet Gynecol       Date:  1992-09       Impact factor: 7.661

View more
  2 in total

Review 1.  Acute myocardial infarction in the obstetric patient.

Authors:  Tabassum Firoz; Laura A Magee
Journal:  Obstet Med       Date:  2012-03-22

2.  Development of an automated imaging pipeline for the analysis of the zebrafish larval kidney.

Authors:  Jens H Westhoff; Stefan Giselbrecht; Miriam Schmidts; Sebastian Schindler; Philip L Beales; Burkhard Tönshoff; Urban Liebel; Jochen Gehrig
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.